Literature DB >> 29138912

Long-Term Follow-Up After Non-operative Management of Blunt Splenic and Liver Injuries: A Questionnaire-Based Survey.

Peter Moreno1, Matthias Von Allmen1, Tobias Haltmeier1, Daniel Candinas1, Beat Schnüriger2.   

Abstract

BACKGROUND: Non-operative management (NOM) of blunt splenic or liver injuries (solid organ injury, SOI) has become the standard of care in hemodynamically stable patients. However, the incidence of long-term symptoms in these patients is currently not known. The aim of this study was to assess long-term symptoms in patients undergoing successful NOM (sNOM) for SOI.
METHODS: Long-term posttraumatic outcomes including chronic abdominal pain, irregular bowel movements, and recurrent infections were assessed using a specifically designed questionnaire and analyzed by univariable analysis.
RESULTS: Eighty out of 138 (58%) patients with SOI undergoing sNOM) responded to the questionnaire. Median (IQR) follow-up time was 48.8 (28) months. Twenty-seven (34%) patients complained of at least one of the following symptoms: 17 (53%) chronic abdominal pain, 13 (41%) irregular bowel movements, and 8 (25%) recurrent infections. One female patient reported secondary infertility. No significant association between the above-mentioned symptoms and the Injury Severity Score, amount of hemoperitoneum, or high-grade SOI was found. Patients with chronic pain were significantly younger than asymptomatic patients (32.1 ± 14.5 vs. 48.3 ± 19.4 years, p = 0.002). Irregular bowel movements were significantly more frequent in patients with severe pelvic fractures (15.4 vs. 0.0%, p = 0.025). A trend toward a higher frequency of recurrent infections was found in patients with splenic injuries (15.9 vs. 2.8%, p = 0.067).
CONCLUSION: A third of patients with blunt SOI undergoing sNOM reported long-term abdominal symptoms. Younger age was associated with chronic abdominal symptoms. More studies are warranted to investigate long-term outcomes immunologic sequelae in patients after sNOM for SOI.

Entities:  

Mesh:

Year:  2018        PMID: 29138912     DOI: 10.1007/s00268-017-4336-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Long-term mental fatigue after traumatic brain injury and impact on employment status.

Authors:  Samuel Palm; Lars Rönnbäck; Birgitta Johansson
Journal:  J Rehabil Med       Date:  2017-03-06       Impact factor: 2.912

2.  Temporal changes in hematologic markers after splenectomy, splenic embolization, and observation for trauma.

Authors:  B Wernick; A Cipriano; S R Odom; U MacBean; R N Mubang; T R Wojda; S Liu; S Serres; D C Evans; P G Thomas; C H Cook; S P Stawicki
Journal:  Eur J Trauma Emerg Surg       Date:  2016-05-11       Impact factor: 3.693

3.  One-year functional outcomes following major trauma: experience of a UK level 1 major trauma centre.

Authors:  Wail Ahmed; Rupali Alwe; Derick Wade
Journal:  Clin Rehabil       Date:  2017-06-05       Impact factor: 3.477

4.  Peritoneal adhesions and their relation to abdominal surgery. A postmortem study.

Authors:  M A Weibel; G Majno
Journal:  Am J Surg       Date:  1973-09       Impact factor: 2.565

5.  Organ injury scaling: spleen and liver (1994 revision).

Authors:  E E Moore; T H Cogbill; G J Jurkovich; S R Shackford; M A Malangoni; H R Champion
Journal:  J Trauma       Date:  1995-03

6.  [Treatment practice in patients with isolated blunt splenic injuries. A survey of Swiss traumatologists].

Authors:  B Schnüriger; F Martens; B M Eberle; P Renzulli; C A Seiler; D Candinas
Journal:  Unfallchirurg       Date:  2013-01       Impact factor: 1.000

7.  Blunt splenic injury in adults: Multi-institutional Study of the Eastern Association for the Surgery of Trauma.

Authors:  A B Peitzman; B Heil; L Rivera; M B Federle; B G Harbrecht; K D Clancy; M Croce; B L Enderson; J A Morris; D Shatz; J W Meredith; J B Ochoa; S M Fakhry; J G Cushman; J P Minei; M McCarthy; F A Luchette; R Townsend; G Tinkoff; E F Block; S Ross; E R Frykberg; R M Bell; F Davis; L Weireter; M B Shapiro
Journal:  J Trauma       Date:  2000-08

8.  Concomitant injuries are an important determinant of outcome of high-grade blunt hepatic trauma.

Authors:  B Schnüriger; D Inderbitzin; M Schafer; R Kickuth; A Exadaktylos; D Candinas
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

9.  Postdischarge complications following nonoperative management of blunt splenic injury.

Authors:  Gil Freitas; Olubode A Olufajo; Khaled Hammouda; Elissa Lin; Zara Cooper; Joaquim M Havens; Reza Askari; Ali Salim
Journal:  Am J Surg       Date:  2016-01-06       Impact factor: 2.565

Review 10.  Evidence-Based Management and Controversies in Blunt Splenic Trauma.

Authors:  D C Olthof; C H van der Vlies; J C Goslings
Journal:  Curr Trauma Rep       Date:  2017-02-09
View more
  3 in total

1.  Are radiological modalities really necessary for the long-term follow-up of patients having blunt solid organ injuries? A single center study.

Authors:  Mehmet Ilhan; Recep Erçin Sönmez; Abdullah Kut; Safa Toprak; Ali Fuat Kaan Gök; Mustafa Kayıhan Günay; Cemalettin Ertekin
Journal:  World J Emerg Med       Date:  2019

2.  Strategies to prevent long-term opioid use following trauma: a Canadian practice survey.

Authors:  Mélanie Bérubé; Caroline Côté; Lynne Moore; Alexis F Turgeon; Étienne L Belzile; Andréane Richard-Denis; Craig M Dale; Gregory Berry; Manon Choinière; Gabrielle M Pagé; Line Guénette; Sébastien Dupuis; Lorraine Tremblay; Valérie Turcotte; Marc-Olivier Martel; Claude-Édouard Chatillon; Kadija Perreault; François Lauzier
Journal:  Can J Anaesth       Date:  2022-09-26       Impact factor: 6.713

3.  Strategies aimed at preventing chronic opioid use in trauma and acute care surgery: a scoping review protocol.

Authors:  Mélanie Bérubé; Lynne Moore; François Lauzier; Caroline Côté; Kelly Vogt; Lorraine Tremblay; Marc-Olivier Martel; Gabrielle Pagé; Pier-Alexandre Tardif; Anne-Marie Pinard; S Morad Hameed; Kadija Perreault; Caroline Sirois; Carole Bélanger; Alexis F Turgeon
Journal:  BMJ Open       Date:  2020-04-14       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.